Concepedia

Author

Brandon W. Higgs

Children's Hospital of PittsburghORCID

Also Known As

B HIGGS, B Higgs, B W Higgs, B. Higgs, B. W. Higgs, B.W. Higgs, BRANDON W. HIGGS, Brandon Higgs, Brandon W Higgs, Brandon W. HIGGS

324

Publications

8.8K

Citations

47

H-Index

105

Concepts

All Affiliations

Children's Hospital of PittsburghUniversity of PittsburghAstraZeneca (United States)Harvard UniversityBrigham and Women's Hospital
BW

About

Brandon W. Higgs is an author at Children's Hospital of Pittsburgh specializing in medicine, immunology, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

22

31

2.4K

2

Engineering

3

3

289

3

Allergy

3

3

292

4

Health Sciences

1

1

407

5

Social Sciences

1

1

15

Brandon W. Higgs

×

95

Publications

7.9K

Citations

45

H-Index

YearCitations

Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non–Small Cell Lung Cancer

Naiyer A. Rizvi, Byoung Chul Cho, Niels Reinmuth,

JAMA Oncology

2020

616

Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery

Suzanne I.S. Mosely, John E. Prime, Richard C.A. Sainson,

Cancer Immunology Research

2016

407

Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway

Brandon W. Higgs, Zheng Liu, Barbara White,

Annals of the Rheumatic Diseases

2011

399

Prognostic and Predictive Impact of Circulating Tumor DNA in Patients with Advanced Cancers Treated with Immune Checkpoint Blockade

Qu Zhang, Jia Luo, Song Wu,

Cancer Discovery

2020

323

Type I Interferon: Potential Therapeutic Target for Psoriasis?

Yihong Yao, Laura K. Richman, Chris Morehouse,

PLoS ONE

2008

305

Neutralization of interferon‐α/β–inducible genes and downstream effect in a phase I trial of an anti–interferon‐α monoclonal antibody in systemic lupus erythematosus

Yihong Yao, Laura K. Richman, Brandon W. Higgs,

Arthritis & Rheumatism

2009

279

Genomic Landscape Survey Identifies SRSF1 as a Key Oncodriver in Small Cell Lung Cancer

Liyan Jiang, Jiaqi Huang, Brandon W. Higgs,

PLoS Genetics

2016

265

Sifalimumab, a Human Anti–Interferon‐α Monoclonal Antibody, in Systemic Lupus Erythematosus: A Phase I Randomized, Controlled, Dose‐Escalation Study

Michelle Petri, Daniel J. Wallace, Alberto Spindler,

Arthritis & Rheumatism

2013

238

Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo

Thomas Karn, Carsten Denkert, Karsten E. Weber,

Annals of Oncology

2020

233

Early Reduction in ctDNA Predicts Survival in Patients with Lung and Bladder Cancer Treated with Durvalumab

Rajiv Raja, Michael Kuziora, Philip Z. Brohawn,

Clinical Cancer Research

2018

227

Page 1